Edwards LifesciencesXSWX:EW +0.37%97 EV-to-FCF is 45.38 as of Jun. 26, 2026, which is 14% below its 10-year median of 52.55. GuruFocus rates XSWX:EW with a GF Score™ of 97/100 and a GF Value™ of CHF75.73. The stock has 5 warning signs investors should review. Among 421 Medical Devices & Instruments companies, Edwards Lifesciences ranks worse than 72.68% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Edwards Lifesciences's Enterprise Value is CHF39,572 Mil.
Edwards Lifesciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was CHF872 Mil. Therefore, Edwards Lifesciences's EV-to-FCF for today is 45.38.
The historical rank and industry rank for Edwards Lifesciences's EV-to-FCF or its related term are showing as below:
XSWX:EW'
s EV-to-FCF Range Over the Past 10 Years
Min: 29.86 Med: 52.55 Max: 219.23
Current: 44.69
During the past 13 years, the highest EV-to-FCF of Edwards Lifesciences was 219.23. The lowest was 29.86. And the median was 52.55.
XSWX:EW's EV-to-FCF is ranked worse than 72.68% of 421
companies
in the Medical Devices & Instruments industry
Industry Median: 22.82
vs XSWX:EW: 44.69
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Edwards Lifesciences's PE Ratio (TTM) for today is calculated as:
Edwards Lifesciences's share price for today is CHF72.91.
Edwards Lifesciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF1.510.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Edwards Lifesciences EV-to-FCF Related Terms
Edwards Lifesciences EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Edwards Lifesciences's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Edwards Lifesciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Edwards Lifesciences EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Edwards Lifesciences's EV-to-FCF falls into.
Edwards Lifesciences's current Enterprise Value is CHF39,572 Mil.
Edwards Lifesciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF872 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Edwards Lifesciences (XSWX:EW) has a EV-to-FCF of 45.38 as of Jun. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Edwards Lifesciences and its competitors. This is 14% below median its historical median of 52.55. Over the past decade, Edwards Lifesciences' EV-to-FCF has ranged from 29.86 to 219.23. According to the industry distribution chart, Edwards Lifesciences ranks #306 out of 421 companies in the Medical Devices & Instruments industry, placing it in the top 72.7%.
Is Edwards Lifesciences' EV-to-FCF too high?
Edwards Lifesciences' current EV-to-FCF of 45.38 is 14% below median its 10-year median of 52.55. Over the past 10 years, this metric has ranged from a low of 29.86 to a high of 219.23. The Medical Devices & Instruments industry median EV-to-FCF is 22.82. Edwards Lifesciences' value of 45.38 is 98.9% above this industry median. Based on the distribution chart, Edwards Lifesciences ranks #306 out of 421 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Edwards Lifesciences has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' EV-to-FCF compare to DXCM and GEHC?
According to the Medical Devices & Instruments industry distribution chart, Edwards Lifesciences ranks #306 out of 421 companies for EV-to-FCF. This places Edwards Lifesciences in the lower half of its industry. The industry median EV-to-FCF is 22.82. Edwards Lifesciences' value of 45.38 is 98.9% above this benchmark. Historically, Edwards Lifesciences' own EV-to-FCF has ranged from 29.86 to 219.23 over the past decade. While the company's 10-year median is 52.55 vs. the industry median of 22.82, Edwards Lifesciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.82, based on 421 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Edwards Lifesciences's current EV-to-FCF of 45.38 is 98.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Edwards Lifesciences and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Edwards Lifesciences's current EV-to-FCF is 45.38, which is 14% below median its own 10-year median of 52.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Edwards Lifesciences (XSWX:EW) has a current EV-to-FCF of 45.38. The stock's GF Value™ is CHF75.73, compared to a current price of CHF72.91 — trading 3.7% below its estimated fair value. The current EV-to-FCF is 45.38, which is 14% below median its 10-year median of 52.55 and 98.9% above the Medical Devices & Instruments industry median of 22.82. Edwards Lifesciences' overall GF Score™ is 97/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Edwards Lifesciences (XSWX:EW), the current EV-to-FCF is 45.38 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Edwards Lifesciences (XSWX:EW) Overvalued in 2026?
Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued.
The current stock price of CHF72.91 is trading 3.7% below its estimated GF Value™ of CHF75.73.
Key valuation signals for XSWX:EW:
EV-to-FCF: 45.38 (14% below median its 10-year median of 52.55)
GF Value™: CHF75.73 vs. price of CHF72.91 (3.7% below fair value)
Industry Position: 98.9% above the Medical Devices & Instruments median (#306 of 421)
No single metric tells the full story. See the XSWX:EW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
97GF Score
Get the complete analysis for XSWX:EW
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:EW has been successfully added to your 
